3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
9
Warts
8
Uterine Cervical Dysplasia
7
Peripheral Nervous System Diseases
5
Stomatitis
4
Prostatic Neoplasms
4
Neoplasms
4
Pain
3
Neoplasm Metastasis
3
Mucositis
3
Uterine Cervical Neoplasms
2
Multiple Myeloma
2
Mesothelioma
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Ductal, Breast
2
Carcinoma, Basal Cell
2
Ulcer
1
Small Cell Lung Carcinoma
1
Retinoblastoma
1
Phyllodes Tumor
1
Pelvic Pain
1
Papillomavirus Infections
1
Neurofibroma, Plexiform
1
Neurofibroma
1
Neoplasms, Plasma Cell
1
NSCLC
1
Musculoskeletal Pain
1
Mesothelioma, Malignant
1
Lymphedema
1
Interventions
Diathermy
9
Radiotherapy
6
Solutions
2
Hydrogen Peroxide
2
Cisplatin
2
Brachytherapy
2
Temozolomide
1
Saline Solution
1
Radiation
1
Laser Therapy
1
Hyperthermic Intraperitoneal Chemotherapy
1
Hyperthermia, Induced
1
Folfox protocol
1
Fluorouracil
1
Electrosurgery
1
Drug Therapy
1
Cytoreduction Surgical Procedures
1
Cryotherapy
1
Control Groups
1
Consolidation Chemotherapy
1
Conization
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Hyperthermia
×
Cryotherapy
×
Clear all
NCT04778631
2025-11-20
PERISAFE
Assistance Publique - Hôpitaux de Paris
Phase NA
Completed
115 enrolled